The modding community has already started working on creating mods for the Minecraft 26.1 Tiny Takeover game drop, which was released on March 24, 2026. This is the first update of 2026, featuring new ...
Harley riders have been hearing the same warning for ages now: install an aftermarket exhaust, tune your bike, or even bolt on a single non-Harley part, and you could lose your Harley-Davidson ...
Usama has a passion for video games and a talent for capturing their magic in writing. He brings games to life with his words, and he's been fascinated by games for as long as he's had a joystick in ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.41187 EPS, ...
Joe Grantham is a contributor from the UK with a degree in Classical Studies. His love for gaming is only rivaled by a deep passion for medieval history, which often seeps into his articles. With over ...
The Marvel Rivals Season 1 update appears to have done more than add the Fantastic Four — players say it's also cracked down on mods. Ever since Marvel Rivals’ hugely successful December launch ...
The artificial intelligence (AI) revolution continues to tout developing drugs faster and at lower cost, but are we there yet? On October 2nd, the FDA cleared an investigational new drug (IND) ...
Granblue Fantasy Relink has many in-game mechanics that you may not like, but you can tweak them with the help of mods. These mods can ensure you get sigils, customize the HUD, repeat quests an ...
Nvidia (NVDA), the Silicon Valley-based microprocessing giant with a growing presence in the life sciences, has spent the first three weeks of this year continuing its climb into the Wall Street ...
Hackers used the popular Minecraft modding platforms Bukkit and CurseForge to distribute a new 'Fractureiser' information-stealing malware through uploaded modifications and by injecting malicious ...
Recursion Pharmaceuticals just acquired a pair of AI-related biotechs. This could bolster its drug discovery capabilities and better help its clients. But the stock is high-risk and requires a ...